Original Article
Gene Therapy (2008) 15, 1513–1522; doi:10.1038/gt.2008.112; published online 24 July 2008
A novel DNA vaccine-targeting macrophage migration inhibitory factor improves the survival of mice with sepsis
S Tohyama1, S Onodera1, H Tohyama1, K Yasuda1, J Nishihira2, Y Mizue3, A Hamasaka4, R Abe4 and Y Koyama2
- 1Department of Sports Medicine and Joint Reconstruction Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan
- 2Department of Medical Information, Hokkaido Information University, Ebetsu, Japan
- 3Sapporo Immuno Diagnostic Laboratory, Sapporo, Japan
- 4Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Correspondence: Dr S Onodera, Department of Sports Medicine and Joint Reconstruction Surgery, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan. E-mail: onodera@hokudai.ac.jp
Received 29 November 2007; Revised 18 May 2008; Accepted 18 May 2008; Published online 24 July 2008.
Abstract
Sepsis is a common and frequently fatal condition and there is an urgent need for new therapies that will further reduce sepsis-induced mortality. Macrophage migration inhibitory (MIF) factor is important in the regulation of innate and adaptive immunity and is believed to play a key regulatory role in sepsis and autoimmune disease. As MIF deficiency or immunoneutralization protects mice or rats from fatal endotoxic shock or other inflammatory diseases, we examined whether DNA vaccination against this molecule would also be protective. DNA vaccines can stimulate both humoral and cellular immunity simultaneously and have been shown to be effective against a variety of pathogens or cytokine-driven pathologies. Mice were immunized with a MIF/tetanus toxin (TTX) DNA vaccine and sepsis was then induced by lipopolysaccharide or cecal ligation and puncture. The MIF/TTX DNA-vaccinated mice were protected from the lethal effect of sepsis compared with control-vaccinated mice in both models. Compared with the control-vaccinated mice, the MIF/TTX DNA-vaccinated mice also showed significantly lower serum tumor necrosis factor (TNF)-
protein levels and reduced mRNA expression of TNF-
, interleukin (IL)-1
, IL-6, macrophage inflammatory protein-2 and Toll-like receptor-4 in the lungs. Thus, the MIF/TTX DNA vaccine may be useful for the prophylaxis of septic shock.
Keywords:
MIF, DNA vaccine, sepsis
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
The stressed hippocampus, synaptic plasticity and lost memories
Nature Reviews Neuroscience Review (01 Jun 2002)
Macrophage migration inhibitory factor: a regulator of innate immunity
Nature Reviews Immunology Review (01 Oct 2003)
NEWS AND VIEWS
Nature Medicine News and Views (01 Feb 2000)
TREM-1: A new regulator of innate immunity in sepsis syndrome
Nature Medicine News and Views (01 May 2001)
RESEARCH
Protection from septic shock by neutralization of macrophage migration inhibitory factor
Nature Medicine Article (01 Feb 2000)
